Melsbroeck, Belgium

Antonio Sereno Guerra

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonio Sereno Guerra: Innovator in Pharmaceutical Technology

Introduction

Antonio Sereno Guerra is a notable inventor based in Melsbroeck, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for medical conditions. His work focuses on enhancing the delivery and efficacy of therapeutic agents.

Latest Patents

Antonio Sereno Guerra holds a patent for an "Orally administrable pharmaceutical pellet of epidermal growth factor." This invention comprises a pellet of epidermal growth factor combined with methionine or KSO. The patent also includes a capsule that contains these pellets, along with processes for their preparation and their use in treating ulcerative colitis. This innovative approach aims to improve patient outcomes through more effective medication delivery.

Career Highlights

Throughout his career, Guerra has worked with prominent organizations in the biotechnology sector. He has been associated with the Centro de Ingeniería Genética y Biotecnología and Biorec S.A. These experiences have allowed him to collaborate with leading experts in the field and contribute to groundbreaking research and development.

Collaborations

Guerra has collaborated with notable colleagues, including Raimundo Ubieta Gómez and Ana Aguilera Barreto. These partnerships have played a crucial role in advancing his research and expanding the impact of his inventions.

Conclusion

Antonio Sereno Guerra is a distinguished inventor whose work in pharmaceutical technology has the potential to transform treatment options for patients with ulcerative colitis. His innovative approaches and collaborations highlight the importance of research and development in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…